3.24
5.19%
0.16
アフターアワーズ:
3.28
0.04
+1.23%
前日終値:
$3.08
開ける:
$3.05
24時間の取引高:
1.49M
Relative Volume:
0.96
時価総額:
$209.69M
収益:
$380.79M
当期純損益:
$49.27M
株価収益率:
-2.6129
EPS:
-1.24
ネットキャッシュフロー:
$10.68M
1週間 パフォーマンス:
+11.34%
1か月 パフォーマンス:
+45.95%
6か月 パフォーマンス:
+14.08%
1年 パフォーマンス:
-82.30%
Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile
名前
Amylyx Pharmaceuticals Inc
セクター
電話
617-683-0917
住所
43 THORNDIKE STREET, CAMBRIDGE
Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-01-03 | 開始されました | Robert W. Baird | Outperform |
2023-12-12 | 開始されました | Deutsche Bank | Buy |
2023-07-24 | アップグレード | Goldman | Neutral → Buy |
2023-03-31 | 開始されました | Mizuho | Buy |
2023-01-05 | 開始されました | BofA Securities | Buy |
2022-05-25 | 開始されました | Citigroup | Buy |
2022-04-01 | ダウングレード | Goldman | Buy → Neutral |
すべてを表示
Amylyx Pharmaceuticals Inc (AMLX) 最新ニュース
Amyotrophic Lateral Sclerosis Treatment Market is Booming with - openPR
Almitas Capital LLC Makes New Investment in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat
XTX Topco Ltd Purchases New Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat
Ratio Analysis: Unpacking America Movil S.A.B.DE C.V. ADR (AMX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Alpha Metallurgical Resources (NYSE:AMR) Shares Up 8.1% - MarketBeat
A year in review: Amylyx Pharmaceuticals Inc (AMLX)’s performance in the last year - US Post News
Insider Sale Alert: Aldeyra Therapeutics Inc [ALDX] – Is it Time to sell? - Knox Daily
A Guide To The Risks Of Investing In Amylyx Pharmaceuticals Inc (AMLX) - Knox Daily
Get in on Aldeyra Therapeutics Inc’s (ALDX) buy-in window today! - SETE News
Acadian Asset Management LLC Purchases Shares of 7,699 Amcor plc (NYSE:AMCR) - Defense World
Meiji Yasuda Life Insurance Co Boosts Holdings in Amcor plc (NYSE:AMCR) - Defense World
AMLX’s Stock Journey: What Investors Need to Know About Amylyx Pharmaceuticals Inc’s Performance - The InvestChronicle
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Stock Catapults 37% Though Its Price And Business Still Lag The Industry - Simply Wall St
Taking a Closer Look At Amarin Corp ADR (AMRN) Following Its Recent Trade - Knox Daily
Amylyx Pharmaceuticals Inc (AMLX)’s Market Momentum: Closing Strong at 2.65, Up 1.15 - The Dwinnex
Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
Examining Amylyx Pharmaceuticals Inc (AMLX) stock is warranted - US Post News
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) CFO James M. Frates Purchases 40,000 Shares - Defense World
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm - ForexTV.com
Does Amylyx Pharmaceuticals Inc (AMLX) offer a good opportunity for investors? - SETE News
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Short Interest Update - MarketBeat
Acadian Asset Management LLC Purchases New Position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Amylyx pharmaceuticals director buys $106,590 in stock - Investing.com
Amylyx pharmaceuticals director buys $106,590 in stock - Investing.com India
Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX) - Yahoo Finance
Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX) By GuruFocus - Investing.com Canada
Amylyx Pharmaceuticals: Management Ambitiously Navigates Challenges (NASDAQ:AMLX) - Seeking Alpha
Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 - Marketscreener.com
Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX) - Yahoo Finance
Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX) By GuruFocus - Investing.com Canada
Amylyx Pharmaceuticals director buys $219,800 in stock - Investing.com India
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Director Purchases $220,000.00 in Stock - MarketBeat
Amylyx Pharmaceuticals director buys $219,800 in stock - Investing.com
Amylyx Pharmaceuticals director buys $219,800 in stock By Investing.com - Investing.com UK
Amyotrophic Lateral Sclerosis Market to Show Remarkable Growth - openPR
Amyotrophic Lateral Sclerosis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Amylyx Pharma, Ionis Pharma, Annexon, Inc., UniQure Biopharma, Sangamo Therapeutics - Barchart
Investigation announced for Long-Term Investors in shares - openPR
Manufacturer to pull controversial ALS drug off the market after failed clinical trial - MSN
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Sees Significant Growth in Short Interest - MarketBeat
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - Elk Valley Times
Oral AMX0035 found to improve core Alzheimer’s-related biomarkers - Alzheimer's News Today
SG Americas Securities LLC Acquires 29,697 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - StockTitan
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - Manchestertimes
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire
Amylyx Pharma pulls ALS drug from US market as it didn't help patients - MSN
Cwm LLC Raises Stock Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Rating of “Hold” from Brokerages - Defense World
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Short Interest Down 50.8% in July - MarketBeat
Amylyx Pharmaceuticals Inc (AMLX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):